Conclusion: the efficacy of treating intermediate and late non-small cell lung cancer with combined taxol and carboplatin chemotherapy is fairly good. The adverse reactions are mild and tolerable.

结论：泰素加卡铂联合化疗方案对中晚期非小细胞肺癌有较好疗效，不良反应小。

youdao

ObjectiveTo study the toxicities and efficacy of late course hyperfractionation accelerated radiotherapy (LCHART) in unresectable locally advanced non-small cell lung cancer (NSCLC).

目的观察局部晚期非小细胞肺癌后程加速超分割放射治疗(lchart)的毒性和疗效。

youdao

Among the bargain stocks, Berry says, is Cell Genesys (nasdaq: CEGE - news - people ), which has a number of products in late stage-three trials, including a vaccine for non-small cell lung cancer.

FORBES: Magazine Article